Weekend round-up
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Independent on Sunday
Halifax building society is asking the Treasury to change the rules to allow it to compete with banks while retaining mutual status.
Michael Heseltine says officials will be knocking on doors of small business to stir them into action.
Camelot, the National Lottery group, faces a pounds 10m a week fine if late with its launch.
Observer
FKI has pulled out of a pounds 400m US takeover because stock market weakness has made a planned rights issue too expensive.
British Gas is well placed to win a contract to pipe Colombian natural gas throughout the capital, Bogota.
Sunday Telegraph
Forte plans to end the struggle over the Savoy Hotel group by converting the controlling B shares into widely held A shares, and incorporating some of its hotels in the chain.
The Government is under pressure to clarify its policy on dividends.
Heron chairman Lord Boardman says he expects to have a shortlist of buyers for the group this week.
Sunday Times
Thorn EMI plans to consider demerging its music and rental operations.
Treasury economists are set to lift their growth forecast for this year from 2.5 to 3 per cent.
Speculation that Glaxo will buy US drug group McKesson has reached fever pitch.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments